Schedule 13G ownership disclosure
Intellipharmaceutics International Inc.
Security class unavailable · CUSIP: 458173309
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,944,978
- Percent of class
- 9.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-19-000063
- Form type
- SC 13G
- Filer
- Intellipharmaceutics International Inc.
- CIK
- CIK 1474835
- Filed
- Jan 29, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership